• DOI:10.1177/1049909111402318
Corpus ID: 19980960

Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity

@article{Carter2011CannabisIP,
  title={Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity},
  author={G. Carter and Aaron M. Flanagan and M. Earleywine and D. Abrams and S. Aggarwal and L. Grinspoon},
  journal={American Journal of Hospice and Palliative Medicine®},
  year={2011},
  volume={28},
  pages={297 - 303}
}

• G. Carter, Aaron M. Flanagan, +3 authors L. Grinspoon
• Published 2011
• Medicine
• American Journal of Hospice and Palliative Medicine®

Unlike hospice, long-term drug safety is an important issue in palliative medicine. Opioids may produce significant morbidity. Cannabis is a safer alternative with broad applicability for palliative care. Yet the Drug Enforcement Agency (DEA) classifies cannabis as Schedule I (dangerous, without medical uses). Dronabinol, a Schedule III prescription drug, is 100% tetrahydrocannabinol (THC), the most psychoactive ingredient in cannabis. Cannabis contains 20% THC or less but has other therapeutic… Expand

View on SAGE

cannabinologist.org

Save to Library

Create Alert

Cite

Launch Research Feed